OncoSec Medical Incorporated announced that on October 1, 2022, James M. DeMesa, M.D. notified the Company of his resignation from the Company's Board of Directors, effective October 1, 2022. Concurrently with such resignation, Dr. DeMesa ceased to serve as Chair of each of the Audit and Nominating and Corporate Governance Committees of the Board and ceased to serve as a member of the Compensation Committee of the Board.